Transferrin Saturation
No Results
No Results
processing….
Transferrin saturations of less than 20% indicate iron deficiency, while transferrin saturations of more than 50% suggest iron overload.
The terms transferrin saturation and iron-binding capacity, saturation, are interchangeable; however, in the last several years, this value is most commonly referred to simply as the transferrin saturation. This also minimizes confusion with another frequently used value, the iron-binding capacity, when determining a patient’s iron status.
The reference range of the transferrin saturation varies by age, as follows: [1]
Adults: 20%-50%
Children: More than 16%
Higher transferrin saturation values are found in high iron states, such as megaloblastic anemia, sideroblastic anemia, and iron overload states. Decreased transferrin saturation values are found in chronic iron deficiency, chronic infection, extensive malignancy, tissue inflammation states, uremia, and nephrotic syndrome.
The value of the transferrin saturation is calculated with the formula below.
(Serum iron level X 100) / total iron-binding capacity
A normal transferrin saturation value is found in patients with normal iron levels.
Details for serum iron-binding capacity (IBC) evaluation are as follows:
Specimen: Blood
Container: Marble-top (serum separator tube [SST]) or red-top tube
Collection method: Routine venipuncture of 6-10 mL
Details for serum iron evaluation are as follows:
Specimen: Blood
Container: Red-top tube
Collection method: Routine venipuncture of 6-10 mL
Transferrin saturation calculation requires the serum iron and IBC values.
Iron tests (including ferritin, iron, transferrin, and IBC) are ideally drawn early in the morning, after a 12-hour fast, when serum iron values are highest. Diurnal variation exists, with iron values lowest in the evening.
Hemolysis during collection of blood specimens may invalidate the accuracy of iron tests. [2]
Iron tests may be less reliable if drawn within 4 days to 1 week of a blood transfusion [3] ; it is also possible that tests and treatments involving the use of radioactive materials can alter iron test results.
Medications should be noted, particularly if the patient is taking multivitamins with iron or oral contraceptives.
Transferrin saturation is typically part of the iron deficiency panel.
The terms transferrin saturation and iron-binding capacity, saturation, are interchangeable; however, in the last several years, this value is most commonly referred to simply as the transferrin saturation. This also minimizes confusion with another frequently used value, the iron-binding capacity, when determining a patient’s iron status.
Iron-binding capacity
To measure the iron-binding capacity (IBC), a standard amount of exogenous iron is added to the patient’s serum in the laboratory. This iron occupies all of the available binding sites and may produce an excess of unbound iron. Then, a standard amount of magnesium carbonate is added, which binds to the unbound iron, forming iron-carbonate complexes.
The sample is centrifuged, removing iron-carbonate complexes, leaving unbound iron in the supernatant. Measurement of this unbound supernatant provides the value of the IBC. [4] This IBC value is therefore an indirect measure of protein transferrin, which binds iron in serum.
Other methods of IBC determination are based on the same principle of adsorbent methods, with charcoal, columns of alumina, or ion-exchange resins. [4]
Transferrin saturation
The transferrin saturation is calculated with the formula below.
(Serum iron level X 100) / total iron-binding capacity
Transferrin saturations of less than 20% indicate iron deficiency, while transferrin saturations of more than 50% suggest iron overload.
Iron tests frequently performed together to diagnose iron deficiency or overload include serum iron, ferritin, IBC, and transferrin levels.
The most common indication for obtaining a transferrin saturation level is to determine a patient’s iron status, either deficiency or overload. [5, 6]
The IBC value and transferrin saturation are best interpreted in the context of additional iron studies (typically, serum iron, ferritin, transferrin) and in the clinical context of the patient’s baseline health state. [7]
After iron repletion, the IBC value may be redrawn with other iron tests to assess therapy.
The IBC is a useful test in determining the stage of iron deficiency. For example, the earliest markers of iron deficiency include ferritin, marrow iron, and IBC. These are followed by serum iron, percentage of transferrin saturation, and decreases in hemoglobin and hematocrit.
In pediatric populations with anemia, a transferrin saturation of less than 16% is diagnostic of iron deficiency anemia. It is limited by diurnal variation in serum iron levels. [8]
Medications that may increase IBC values include fluorides and birth control pills. Medications that can decrease IBC values include adrenocorticotropic hormone (ACTH) and chloramphenicol.
In states of iron overload, with resulting excess iron deposition in tissues, excess free iron can result in cirrhosis, diabetes, cardiomyopathy, arthritis, and other endocrine disorders; [9] thus, it is important to monitor iron tests, including IBC and transferrin saturation values.
Examples can be found throughout the literature of attempts to correlate a TIBC or transferrin saturation value to a particular disorder. For example, a recent retrospective study found that men with anemia should undergo a thorough endoscopic evaluation to assess for gastrointestinal neoplasms when the transferrin saturation value is 9% or less. [10] Further studies are needed to determine if IBC and transferrin saturation values may be diagnostic in other disorders.
Furthermore, investigators have also tried to establish goal values of transferrin saturation in particular disorders. For example, in patients with chronic kidney disease, the 2006 Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines recommend assessment of iron tests to determine the contribution of iron deficiency to anemia. The KDOQI recommends maintaining a transferrin saturation of 20% or more to ensure adequate supply of iron for erythropoiesis in patients on stimulating agents. [11]
Delmar’s Guide to Laboratory and Diagnostic Tests. 2nd Ed. 2010.
Ocasio HE, Diaz H, Cangiano JL, Baez R, Suarez E. Anemia management among hemodyalisis patients at the University Hospital in Puerto Rico. Bol Asoc Med P R. 2014. 106(2):9-12. [Medline].
Smith GA, Fisher SA, Doree C, Di Angelantonio E, Roberts DJ. Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors. Cochrane Database Syst Rev. 2014 Jul 3. 7:CD009532. [Medline].
Siff JE, Meldon SW, Tomassoni AJ. Usefulness of the total Iron-binding capacity in the evaluation and treatment of acute iron overdose. Ann Emerg Med January. 1999. 33:73-76.
Li J, Lange LA, Duan Q, Lu Y, Singleton AB, Zonderman AB, et al. Genome-Wide Admixture and Association Study of Serum Iron, Ferritin, Transferrin Saturation, and Total Iron Binding Capacity in African Americans. Hum Mol Genet. 2014 Sep 15. [Medline].
Bach V, Schruckmayer G, Sam I, Kemmler G, Stauder R. Prevalence and possible causes of anemia in the elderly: a cross-sectional analysis of a large European university hospital cohort. Clin Interv Aging. 2014. 9:1187-96. [Medline]. [Full Text].
Aigner E, Feldman A, Datz C. Obesity as an Emerging Risk Factor for Iron Deficiency. Nutrients. 2014 Sep 11. 6(9):3587-3600. [Medline].
Kliegman RM, Stnton BF, Geme JW, Schor NF, Behrman RE. Nelson Textbook of Pediatrics. 19th ed. Elsevier; 2011.
McPherson RA, Pincus M. Henry’s Clinical Diagnosis and Management by Laboratory Methods. 22nd ed. 2012.
Lee MH, Park E, Lee J, Kim SY, Kim SY, Lee SY, et al. Cutoff values of serum ferritin and TIBC saturation for the evaluation of gastrointestinal neoplasms in adult anemic patients. Int J Hematol. 2012 Jun 28. [Epub ahead of print].
Atkinson MA, Pierce CB, Fadrowski JJ, Benador NM, White CT, Turman MA, et al. Association between common iron store markers and hemoglobin in children with chronic kidney disease. Pediatr Nephrol. 2012 Jul 27. [Epub ahead of print].
Adamson JW. Iron Deficiency and other Hypoproliferative Anemias. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds. Harrison’s Principles of Internal Medicine, 18e. The McGraw-Hill Companies;
Shalini Paruthi, MD Assistant Professor of Pediatrics and Internal Medicine, St Louis University School of Medicine
Shalini Paruthi, MD is a member of the following medical societies: American Academy of Sleep Medicine
Disclosure: Nothing to disclose.
Eric B Staros, MD Associate Professor of Pathology, St Louis University School of Medicine; Director of Clinical Laboratories, Director of Cytopathology, Department of Pathology, St Louis University Hospital
Eric B Staros, MD is a member of the following medical societies: American Medical Association, American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology
Disclosure: Nothing to disclose.
Transferrin Saturation
Research & References of Transferrin Saturation |A&C Accounting And Tax Services
Source